Trovagene aims to price public offering of common stock with greenshoe

Aegis, Summer Street help finance research and development activities

By Devika Patel

Knoxville, Tenn., April 19 - Trovagene Inc. will price a public offering of common stock with a 45-day greenshoe option, according to a Form S-1 filed Thursday with the Securities and Exchange Commission.

Aegis Capital Corp. and Summer Street Research Partners are the underwriters.

Proceeds will be used for research and development activities, working capital and general corporate purposes and possible acquisitions.

The company's stock (Pink Sheets: TROV) closed at $0.72 per share on April 16.

Trovagene is a molecular diagnostic company in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.